Bombardier Inc. (TSX:BBD.A)

CTI BioPharma Revenue

Bombardier had revenue of $2.03B USD in the quarter ending June 30, 2025, a decrease of -7.94%. This brings the company's revenue in the last twelve months to $8.73B, up 3.92% year-over-year. In the year 2024, Bombardier had annual revenue of $8.67B with 7.69% growth.

• Revenue (ttm): $8.73B
• Revenue Growth: +3.92%
• P/S Ratio: 1.36
• Revenue / Employee: $487.77K
• Employees: 17,900
• Market Cap: 16.25B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.67B	619.00M	7.69%
Dec 31, 2023	8.05B	1.13B	16.39%
Dec 31, 2022	6.91B	828.00M	13.61%
Dec 31, 2021	6.09B	-402.00M	-6.20%
Dec 31, 2020	6.49B	-1.00B	-13.37%